Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00806728 · ClinicalTrials.gov registry record · Phase 1
Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease
A Phase 1 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT00806728 is a Phase 1 study that has completed, run by MedImmune. The registered enrollment target is 17 participants.
The verdict
NCT00806728, a Phase 1 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
A clinical trial to assess safety and two regimens of (MEDI-507) a drug given to stem cell and bone marrow recipients who have a mid-grade acute Graft-versus-Host Disease.
Interventions
- DRUG MEDI-507
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 1998-05 |
| Est. Completion | 1998-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00806728
The ClinicalTrials.gov registry entry for NCT00806728 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MEDI-507 is the first listed.
NCT00806728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00806728 about?
NCT00806728 is a clinical study titled "Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease". A clinical trial to assess safety and two regimens of (MEDI-507) a drug given to stem cell and bone marrow recipients who have a mid-grade acute Graft-versus-Host Disease.
What is the current status of trial NCT00806728?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 1998-05. Estimated completion is 1998-12.
What interventions are being tested in trial NCT00806728?
The interventions under investigation include: MEDI-507 (DRUG).
Who is sponsoring clinical trial NCT00806728?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.